Option chain shows key data for Freshpet's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Freshpet.

Freshpet (NASDAQ:FRPT) Stock, Option Chain

Freshpet

Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. The former two store types accounted for 89% of 2023 sales, with grocery stores representing the primary driver of footprint growth. Freshpet primarily targets dogs (92% of sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 96% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.

Wall-Street-ai7-1

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

CALM

FRPT

Top 3 Risk Off Stocks That May Collapse This Quarter

xr:d:DAFeeIkW91A:2,j:1670940971,t:23032808

Price Target

Analyst Ratings

ACLX

APLS

LION

LULU

NXPI

Lululemon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday

Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Intraday Update

Movers

AIXI

ARRY

ATSG

BBWI

CHWY

GSAT

IART

IRON

NGNE

PSNY

PTON

YUMC

Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday

Freshpet Inc

As of Nov. 20, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Energizer Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>)</h3>
<ul>
<li>On Nov. 19, Energizer Holdings reported better-than-expected fourth-quarter adjusted EPS results. &#8220;We finished fiscal 2024 with solid performances across both Battery and Auto Care, driving adjusted earnings growth above our initial expectations,&#8221; said Mark LaVigne, President and Chief Executive Officer. The company's stock gained around 15% over the past month and has a <a href="https://www.benzinga.com/quote/ENR">52-week high of $39.21</a>.</li>
<li>RSI Value: 88.06&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>ENR Price Action: Shares of Energizer gained 9.1% to close at $37.25 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Freshpet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>)</h3>
<ul>
<li>On Nov. 4, Freshpet reported better-than-expected third-quarter financial results and raised its full-year adjusted EBITDA outlook. &#8220;Our third quarter results demonstrate the strength and consistency of both net sales and profitability growth we have been striving to deliver. We delivered our 25th consecutive quarter of >25% year on year net sales growth and matched that with a very strong operating performance. This further strengthens our confidence in our ability to meet or exceed our 2027 goals,&#8221; commented Billy Cyr, Freshpet&#8217;s Chief Executive Officer. The company's stock gained around 14% over the past month and <a href="https://www.benzinga.com/quote/FRPT">has a 52-week high</a> of $159.12.</li>
<li>RSI Value: 72.43</li>
<li>FRPT Price Action: Shares of Freshpet gained 3.9% to close at $156.38 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Cal-Maine Foods Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>)</h3>
<ul>
<li>On Oct. 1, the company posted better-than-expected quarterly earnings. Sherman Miller, president and chief executive officer of Cal-Maine Foods, stated, &#8220;Our financial and operating results for the first quarter mark a strong start to fiscal 2025 for Cal-Maine Foods. These results reflect favorable demand for shell eggs during most of the quarter and significantly higher market prices compared with the first quarter last year.&#8221; The company's stock gained around 4% over the past month and has a <a href="https://www.benzinga.com/quote/CALM">52-week high</a> of $96.02.</li>
<li>RSI Value: 70.14</li>
<li>CALM Price Action: Shares of Cal-Maine gained 1.3% to close at $95.14 on Tuesday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42069785/wall-streets-most-accurate-analysts-weigh-in-on-3-defensive-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 5% Dividend Yields</a></li>
</ul>

Oppenheimer analyst Rupesh Parikh maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Outperform and raises the price target from $155 to $180.

Oppenheimer Maintains Outperform on Freshpet, Raises Price Target to $180

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Needham cut Apellis Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) price target from $85 to $60. Needham analyst Joseph Stringer maintained a Buy rating. Apellis Pharmaceuticals shares closed at $28.08 on Tuesday. See how other analysts view this stock.</li>
<li>Deutsche Bank raised the price target for Emerson Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) from $136 to $140. Deutsche Bank analyst Nicole Deblase maintained a Buy rating. Emerson Electric shares closed at $117.67 on Tuesday. <a href="https://www.benzinga.com/quote/EMR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HC Wainwright &amp; Co raised the price target for Arcellx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLX#NASDAQ">ACLX</a>) from $80 to $95. HC Wainwright &amp; Co. analyst Emily Bodnar maintained a Buy rating. Arcellx shares closed at $87.12 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley slashed NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) price target from $250 to $235. Morgan Stanley analyst Joseph Moore maintained an Equal-Weight rating. NXP Semiconductors shares settled at $224.65 on Tuesday. <a href="https://www.benzinga.com/quote/NXPI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel raised Freshpet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) price target from $155 to $165. Stifel analyst Mark Astrachan maintained a Buy rating. Freshpet shares closed at $151.59 on Tuesday. <a href="https://www.benzinga.com/quote/FRPT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird increased Choice Hotels International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHH#NYSE">CHH</a>) price target from $138 to $145. Baird analyst Michael Bellisario maintained an Outperform rating. Choice Hotels shares closed at $139.46 on Tuesday. <a href="https://www.benzinga.com/quote/CHH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird raised the price target for Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) from $350 to $380. Baird analyst Mark Altschwager maintained an Outperform rating. Lululemon shares settled at $319.23 on Tuesday. <a href="https://www.benzinga.com/quote/LULU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley raised Broadridge Financial Solutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BR#NYSE">BR</a>) price target from $200 to $207. Morgan Stanley analyst James Faucette maintained an Equal-Weight rating. Broadridge Financial shares closed at $218.30 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird boosted the price target for Cummins Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NASDAQ">CMI</a>) from $330 to $372. Baird analyst David Leiker maintained a Neutral rating. Cummins shares closed at $354.46 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley cut Lionsgate Studios Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) price target from $133 to $173. Truist Securities analyst Jamie Cook upgraded the stock from Hold to Buy. Lionsgate Studios shares closed at $6.76 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>

Stifel analyst Mark Astrachan maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $155 to $165.

Stifel Maintains Buy on Freshpet, Raises Price Target to $165

DA Davidson analyst Brian Holland maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $183 to $189.

DA Davidson Maintains Buy on Freshpet, Raises Price Target to $189

TD Cowen analyst Robert Moskow maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $160 to $174.

TD Cowen Maintains Buy on Freshpet, Raises Price Target to $174

JP Morgan analyst Ken Goldman maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Neutral and raises the price target from $126 to $154.

JP Morgan Maintains Neutral on Freshpet, Raises Price Target to $154

Truist Securities analyst Bill Chappell maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $160 to $170.

Truist Securities Maintains Buy on Freshpet, Raises Price Target to $170

Wells Fargo analyst Marc Torrente maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Overweight and raises the price target from $157 to $175.

Wells Fargo Maintains Overweight on Freshpet, Raises Price Target to $175

Deutsche Bank analyst Stephen Powers maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $161 to $163.

Deutsche Bank Maintains Buy on Freshpet, Raises Price Target to $163

Benchmark analyst John Lawrence maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $150 to $185.

Benchmark Maintains Buy on Freshpet, Raises Price Target to $185

Baird analyst Peter Benedict maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Outperform and raises the price target from $157 to $170.

Baird Maintains Outperform on Freshpet, Raises Price Target to $170

U.S. stocks were lower, with the Dow Jones index falling around 300 points on Monday.
Shares of Integra LifeSciences Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) rose sharply during Monday's session after the company reported better-than-expected third-quarter financial results.
Integra Lifesciences reported quarterly earnings of 41 cents per share which beat the analyst consensus estimate of 39 cents per share. The company reported quarterly sales of $380.83 million which beat the analyst consensus estimate of $375.78 million.
Integra LifeSciences shares jumped 24.4% to $23.96 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Neurogene Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGNE#NASDAQ">NGNE</a>) shares jumped 43% to $66.22 after the company entered a securities purchase agreement for a PIPE investment, expected to bring in gross proceeds of $200 million.</li>
<li>Air Transport Services Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATSG#NASDAQ">ATSG</a>) gained 26.4% to $22.01 after the company announced it will be acquired by Stonepeak for approximately $3.1 billion, with shareholders receiving $22.50 per share in cash.</li>
<li>Xiao-I Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) rose 24.2% to $7.14. Xiao-I entered into private placement &amp; securities purchase agreement to issue, sell convertible promissory note for $2.1 million.</li>
<li>Disc Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRON#NASDAQ">IRON</a>) gained 22.9% to $57.93 after the company announced the end of its Phase 2 Bitopertin In Erythropoietic Protoporphyria meeting with the FDA. The company is aligned with the FDA across all proposed study parameters and has a clear development path to registration.</li>
<li>Globalstar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSAT#NASDAQ">GSAT</a>) gained 21.8% to $1.6800.</li>
<li>Canopy Growth Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) rose 16% to $5.64.</li>
<li>The Chemours Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>) gained 14.6% to $20.42 after the company reported better-than-expected quarterly financial results.</li>
<li>Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) rose 13.5% to $7.61.</li>
<li>Evotec SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NYSE">EVO</a>) jumped 13.1% to $4.3850.</li>
<li>LexinFintech Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LX#NYSE">LX</a>) gained 12.8% to $3.6100.</li>
<li>Freshpet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) gained 10.9% to $148.32 after the company reported better-than-expected quarterly financial results and raised its full-year adjusted EBITDA outlook.</li>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) rose 9.4% to $10.88.</li>
<li>Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) surged 8.1% to $48.73 after the company reported better-than-expected quarterly EPS and revenues.</li>
<li>Nextracker Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) gained 8% to $42.75.</li>
<li>Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) rose 7.5% to $7.80.</li>
<li>Polestar Automotive Holding UK PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) gained 7.5% to $1.2250.</li>
<li>Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) gained 7.3% to $29.13 after it was announced that the company will join the S&amp;P MidCap 400 prior to the opening of trading on Wednesday, Nov. 6.</li>
<li>Bath &amp; Body Works, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NASDAQ">BBWI</a>) rose 7.2% to $30.99.</li>
<li>Advance Auto Parts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) gained 5.6% to $ 38.29</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41713625/this-roblox-analyst-turns-bullish-here-are-top-5-upgrades-for-monday">This Roblox Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday</a></li>
</ul>

Freshpet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) shares are trading higher after the company reported better-than-expected <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41708955/freshpet-inc-reports-third-quarter-2024-financial-results" rel="noreferrer noopener">third-quarter results</a>.
EPS for the quarter was $0.24, an improvement from a loss of $0.15 a year ago, <a href="https://www.benzinga.com/earnings">topped the analyst consensus of $0.08.</a>
Quarterly sales of $253.367 million beat the street view of $248.211 million. Volume gains of 26.1% primarily drove the increase in net sales.
For the third quarter, adjusted gross profit was $117.7 million, or 46.5% of net sales, compared to $80.6 million, or 40.2% of net sales, for the prior year period.
Adjusted EBITDA rose $20.2 million YoY to $43.5 million, and margin expanded by 560 bps to 17.2%.
As of September 30, the company had cash and equivalents of $274.6 million, with $394.6 million of debt outstanding net of $7.9 million of unamortized debt issuance costs.
Cash from operations for the nine months ended September end was $103.9 million, compared to $38.97 million a year ago. For the quarter, operating cash flow was $56.1 million.
The company <a target="_blank" href="https://investors.freshpet.com/static-files/1ccc3173-3897-4223-8660-c6ebf399af39" rel="noreferrer noopener">achieved </a>a 790 basis point improvement in quality, input, and logistics costs in the quarter, with adjusted gross margin and cost efficiencies surpassing long-term targets, supported by focused workforce training.
&#8220;Our&nbsp;third quarter&nbsp;results demonstrate the strength and consistency of both net sales and profitability growth we have been striving to deliver. We delivered our 25th consecutive quarter of &gt;25%&nbsp;year on year net sales growth and matched that with a very strong operating performance. This further strengthens our confidence in our ability to meet or exceed our 2027 goals,&#8221; commented Billy Cyr, Freshpet&#8217;s Chief Executive Officer.
&#8220;We are raising our net sales and Adjusted EBITDA&nbsp;guidance&nbsp;for 2024 to reflect this continued strong performance and our confidence in our ability to finish the year strongly and, as a result, create significant shareholder value in a way that serves pets, people, and the planet.&#8221;
2024 Outlook, raised: FRPT now sees net sales of ~$975 million (prior expectation at least $965 million) <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">versus consensus of $969.47 million.</a>
The company expects Adjusted EBITDA of at least $155 million (prior expectation $140 million) and capital expenditures of ~$180 million (prior $200 million).
Price Action: FRPT shares are trading higher by 6.96% to $143.00 at last check Monday.

Earnings

Equities

Guidance

Freshpet Surges On Strong Q3 Earnings Beat, 25th Quarter Of Double-Digit Sales Growth: Details

WIIM

Freshpet shares are trading higher after the company reported better-than-expected Q3 financial results and raised its full-year adjusted EBITDA outlook.

Freshpet Sees FY24 Net Sales $965M-$975M vs $969.47M Est., Raised Full-Year Adjusted EBITDA Outlook From $140M+ To $155M+

Earnings Beats

Freshpet Q3 2024 GAAP EPS $0.24 Beats $0.08 Estimate, Sales $253.367M Beat $248.211M Estimate

Benchmark analyst John Lawrence reiterates Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and maintains $150 price target.

Reiteration

Benchmark Reiterates Buy on Freshpet, Maintains $150 Price Target

Stifel analyst Mark Astrachan maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $135 to $155.

Stifel Maintains Buy on Freshpet, Raises Price Target to $155

Truist Securities analyst Bill Chappell maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $135 to $160.

Truist Securities Maintains Buy on Freshpet, Raises Price Target to $160

Freshpet rallies as upbeat Q3 results leads to raised full year guidance

TD Cowen analyst Robert Moskow has maintained their bullish stance on FRPT stock, giving a Buy rating on November 1. Robert Moskow's rating is base...

Freshpet's Robust Performance and Optimistic Outlook Justify Buy Rating

Freshpet Inc ( ($FRPT) ) has released its Q3 earnings. Here is a breakdown of the information Freshpet Inc presented to its investors. Freshpet Inc...

Freshpet Inc. Reports Strong Q3 2024 Performance

Baird raised the firm's price target on Freshpet (FRPT) to $170 from $157 and keeps an Outperform rating on the shares. The firm said they posted a...

Freshpet price target raised to $170 from $157 at Baird

Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Oatly Group (OTLY – Research Report), Coles Gr...

Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Oatly Group (OTLY), Coles Group Ltd. (OtherCLEGF) and Freshpet (FRPT)

Deutsche Bank raised the firm's price target on Freshpet (FRPT) to $163 from $161 and keeps a Buy rating on the shares post the Q3 report. Publishe...

Freshpet price target raised to $163 from $161 at Deutsche Bank

Virtual Meeting to be held on November 5 hosted by Benchmark. Published first on TheFly – the ultimate source for real-time, market-moving breaking...

Freshpet management to meet virtually with Benchmark

Stifel raised the firm's price target on Freshpet (FRPT) to $165 from $155 and keeps a Buy rating on the shares. The firm lifts its 2024-2027 sales...

Freshpet price target raised to $165 from $155 at Stifel

In a report released today, Mark Astrachan from Stifel Nicolaus maintained a Buy rating on Freshpet (FRPT – Research Report), with a price target o...

Freshpet (FRPT) Receives a Buy from Stifel Nicolaus

Oppenheimer raised the firm's price target on Freshpet (FRPT) to $180 from $155 and keeps an Outperform rating on the shares after hosting in-perso...

Comments

Freshpet

Freshpet (FRPT) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga